Eli Lilly expects to launch the medicine around the world around this time next year
These typically improve over weeks
Meanwhile, macronutrient tracking and Success Kit updates include a protein tracker and a high protein tag for foods with a high protein-to-calorie ratio
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) A substudy of the phase 2 obesity trial specifically examined GLP3 s effects on liver fat in participants with metabolic dysfunction-associated steatotic liver disease[12]: Mean relative liver fat reduction of 82.4% with 12 mg dose at 24 weeks 86% of participants on 12 mg achieved normal liver fat levels (below 5%) at 24 weeks Liver fat reductions significantly correlated with improvements in insulin sensitivity, abdominal fat, and metabolic parameters Dose-dependent improvements observed across all dose groups compared to placebo These results suggest potential therapeutic applications beyond weight management, addressing hepatic complications of obesity and metabolic syndrome
That gives 5mg/mL, where the early titration doses land on clean, round numbers: 0.5mg = 10 units, 1mg = 20 units, 2mg = 40 units, 4mg = 80 units, 8mg = 160 units
*Based on self-reported member data on a Found program from members with no prior weight loss medication use, as of April 2026: 12.1% weight loss in 6 months on compounded tirzepatide, and 8.3% in 3 months on compounded tirzepatide vs
